Namrata Vijayvergia MD FACP

PubMed

• Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer.
  Anush Sridharan, Efrat Dotan, Marianna Dorta, Navya Vemula, Elizabeth Handorf
  Journal of Gastrointestinal Cancer. 2025-02-15
• 10 citations
  Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
  Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr
  The New England Journal of Medicine. 2025-02-13
• TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.
  Patrick M Boland, Sarbajit Mukherjee, Iman Imanirad, Namrata Vijayvergia, Seth D Cohen
  British Journal of Cancer. 2024-11-01

Journal Articles

• Differences in patterns of care and outcomes of elderly versus younger metastatic pancreatic cancer (mPC) patients  
  Vijayvergia, N., Dotan, E., Cohen, S.J., J Clin Oncol, 1/1/2013
• Diagnostic Approach to a Patient with Paraneoplastic Neurological Syndrome  
  Mahta, A., Vijayvergia, N.,Ward, L. D., World Journal of Oncology, 1/1/2012

Abstracts/Posters

• "NUT Midline Carcinomas"
  Namrata (Neena) Vijayvergia, MD, Multidisciplinary Oncology Case Conference, Temple University Hospital, Philadelphia, 1/1/2013
• "Thrombotic Microangiopathy: A Focus on Atypical HUS"
  Namrata (Neena) Vijayvergia, MD, Case Based Hematology Conference, Temple University Hospital, Philadelphia, 1/1/2013
• "Hereditary Breast Cancer"
  Namrata (Neena) Vijayvergia, MD, Fellows Case Conference, Fox Chase Cancer Center, 1/1/2012
• Paraneoplastic Encephalopathy and Ataxia in a Patient with Small Cell Lung Cancer.
  Mahta, A., Vijayvergia,N., ACP Pennsylvania Chapter Southeastern Region, 1/1/2011
• Join now to see all

Lectures

• "Chronic Myelogenous Leukemia: Chronic malignancy in true sense?" 
  Temple University Hospital, Philadelphia - 1/1/2014
• "Medical management of Locally Advanced Esophageal Cancer" 
  Fox Chase Cancer Center - 1/1/2013
• "Chemotherapy in Pancreatic Cancer: Where we are and where we are heading" 
  Fox Chase Cancer Center - 1/1/2013